Position in KRYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,204,120
+$1,558,194 QoQ
Shares Held
14,002
-0.8% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#110
of 419 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,401 across 216 Biotechnology names. KRYS ranks #78 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in KRYS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,204,120 | 14,002 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $3,645,926 | 14,114 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $3,490,264 | 14,157 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $3,554,077 | 20,133 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,645,119 | 11,968 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $2,187,217 | 12,131 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $1,463,046 | 9,339 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,519,950 | 8,350 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,393,276 | 7,587 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,073,985 | 6,036 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $533,706 | 4,302 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $465,624 | 4,014 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $522,547 | 4,451 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $315,756 | 3,944 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $293,747 | 3,708 | Shares | Defined | 2023-02-14 | |
| 2020-06-30 | $346,975 | 8,377 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $531,722 | 12,297 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||